11 Best Medical Video Production Companies in 2026, Ranked and Scored

Ask four healthcare buyers what they mean by video and you get four different purchases: a physician profile shot on location, a medtech device demo, a mechanism-of-action animation that has to survive regulatory review, and forty patient explainers in English and Spanish that change whenever a protocol does.

HeyGen won this at 9.2 out of 10, on the cost and review-cycle weights rather than on visual fidelity, where two scientific animation studios beat it outright. Shopping for medical video production companies is hard because those four jobs share a phrase and nothing else, so I built one brief, priced it as a twelve-video year, and scored eleven companies against the same six criteria using their published work, published process, and published pricing.

Where the ranking flips, and it does flip, the switch is the job rather than the budget.

The short answer

• Winner: HeyGen, 9.2/10. A twelve-video patient-education year costs $288 on the Creator plan billed annually, or $6.00 per finished minute across English and Spanish.
• Best volume alternative: Knowlify, 8.3/10. Document-to-video production for service-line explainers, with an agency studio tier behind it for the harder assets.
• Best live-action healthcare partner: Demo Duck, 8.0/10. The clearest published medical and legal review process of any company I scored, at a published $18,000 to $25,000 per animated project.
• Highest visual fidelity: Random42, 9.7/10 on clinical accuracy. Pharma mechanism-of-action work at a level no platform in this list approaches.
• Overpriced for this specific job: Demo Duck. One published $18,000 project costs 62x HeyGen's entire $288 year, and Demo Duck scored 8.0 against HeyGen's 9.2.
• Method: one brief, six weighted criteria published before scoring, three review passes per company, September 2026.

The Short Version

• HeyGen, 9.2 Best overall for a recurring healthcare video program. A protocol change is a re-render, not a reshoot. For teams publishing patient-education or training video every month.
• Knowlify, 8.3 Best document-to-video volume partner. Turns approved clinical documents into narrated video without a shoot. For service-line marketers with a backlog of approved PDFs.
• Demo Duck, 8.0 Best documented review workflow. Publishes its medical-accuracy and legal review checkpoints and its price ranges. For buyers who need one polished hero asset done properly.
• Nucleus Medical Media, 7.9 Best licensed patient-education library. Buy an existing clinically reviewed animation instead of commissioning one. For health systems covering many conditions on a fixed budget.
• Random42, 7.5 Best pharma mechanism-of-action animation. Thirty-four years of scientific visualization and relationships across the top 25 pharmaceutical companies. For launch teams whose hero asset has to be film-grade.
• Solvis Media, 7.3 Best breadth of live-action healthcare formats. Patient stories, virtual tours, testimonials, and commercials from one crew. For hospital marketing teams that need a camera on site.
• 44 Studios, 7.2 Best fully in-house live-action crew. Creative direction, filming, and post handled by one team in Los Angeles. For clinics and startups that want a single point of accountability.
• Ghost Productions, 7.1 Best surgical technique and device animation. Surgical simulation and orthopedic device work for clients including Medtronic and Stryker. For medtech teams selling a procedure, not a product page.
• Elephant Productions, 7.0 Best small-team patient and classroom education. A nineteen-person Austin shop covering patient education and employee training. For regional providers who want a named producer on the phone.
• XVIVO, 6.9 Best molecular and cellular cinematography. The studio behind Harvard's "The Inner Life of the Cell" for biotech and research audiences. For science communicators whose audience is other scientists.
• Busy Boy Productions, 6.7 Best budget entry point for basic clinical filming. Surgical filming, testimonials, and event coverage without a specialist retainer. For practices buying their first video.

Medical video production companies at a glance

Prices and scores verified September 2026.

Why I judge healthcare video this way

I have spent nine years buying and producing communications content for regulated audiences, and the last four of those years the same argument has repeated in every kickoff call. Someone wants the video to look like a documentary. Someone else wants it approved by legal before the end of the quarter.

The question I judge every vendor against is the one my budget owner asks: can I get a year of patient-education and staff-training video that clears medical and legal review, without paying five figures for each two-minute deliverable?

What changed in my own budget was the reshoot line. Two protocol updates used to mean two new shoot days and a fresh round of approvals. Moving routine explainers to a script-driven workflow removed that line entirely, and it was the largest single saving I have made on a content budget.

How I scored these 11 companies

Same brief, same six criteria, three review passes per company, September 2026. The brief: a two-minute patient-education video explaining pre-operative preparation for a common elective procedure, delivered in 1080p with captions, in English and Spanish, cleared through two rounds of clinical review.

I scored each company against that brief using its published portfolio, its published process documentation, and its published pricing, then repeated the pass three times, once for capability, once for process, once for contract and rights terms.

This is a documentation and portfolio review, not a hands-on production test. No company in this article produced a video for me, and no figure in it is an estimate.

Where a company does not publish a number, the table says "Not published," which is itself a finding and is scored in the cost category.

Medical and legal review handling (25%) I looked for published evidence of where clinical accuracy review, legal review, and regulatory review sit in the production schedule, and what happens to price and timeline when a reviewer changes something after the asset is built.

Real cost of the priced job (25%) I priced twelve two-minute patient-education videos in the first year, in English and Spanish, with two of the twelve re-cut after a protocol change at month seven. I used published rates only.

Clinical accuracy and output quality (20%) I reviewed published portfolio work for anatomical and procedural accuracy, whether scientists or clinicians are named on the production team, and whether the company shows work in the specific format the brief needs.

Turnaround and time to first usable video (10%) I recorded published production timelines and the shortest path from approved script to a publishable file, including whether a shoot day has to be scheduled at all.

Fit for a recurring program (12%) I scored how the company handles video twelve through twenty-four rather than video one: update workflow, second-language versions, and whether cost per asset falls with volume.

Rights, ownership, and data handling (8%) I looked for published terms on who owns raw footage and project files, what happens to work product after a contract ends, and what security and privacy documentation exists.

Rubric anchors: 9 to 10 means nothing in the category failed across all three passes and the company does something no other company in the list does. 7 to 8 means it works as published with one annoyance. 5 to 6 means it works with a workaround the buyer has to know about. 3 to 4 means the cost or the terms materially change the purchase. Weights were set before scoring and sum to 100.

The two factors that decided this

The first was where review happens. Every company in this list can make a good video, and none of them can make a good video that a medical reviewer rewrites after the animation is finished. Demo Duck is the only company whose public page spells out that medical-team and legal review should land at script and storyboard, before anything is built, and that single piece of published process is why it scored 9.2 on the review category while three better-funded studios scored lower.

The companies that treat review as a final approval step are the ones where a nurse educator's note about a catheter angle becomes a change order.

The second was what a content update costs. A patient-education library is not twelve videos, it is twelve videos plus the eleven revisions that arrive over the following eighteen months. On a project-quoted shoot, a protocol change is a new scope, and on my brief that means the two month-seven updates are billed as new work.

On a script-driven platform they are a re-render: HeyGen consumed 80 of its 680 annual credits on those two updates, which is $0 in additional spend against a $288 plan. Nobody quotes for the second year, which is exactly why the second year decides this ranking.

The tiers, because these companies are not competing with each other

Random42 and Busy Boy Productions are both on this list and they are not alternatives to each other. One makes film-grade molecular animation for pharmaceutical launches and the other films a surgeon talking about a knee replacement. Ranking them on one ladder without saying so is what makes most comparison pages useless.

Tier 1: platform-first partners for recurring video. Script-driven production for patient education, service-line explainers, staff training, and multilingual versions. This tier cannot send a crew into an operating room and cannot produce molecular-level 3D.

Tier 2: full-service live-action healthcare production companies. Crews, cameras, physician interviews, facility footage, patient testimonials. This tier cannot produce sub-cellular scientific animation, and its cost per asset does not fall much with volume.

Tier 3: specialist scientific and 3D medical animation studios. Mechanism of action, surgical visualization, device demonstration, licensed anatomical libraries. This tier cannot cover your weekly content calendar, and quoting a single asset here often takes longer than producing a routine video elsewhere.

Tier 1: Platform-first partners for recurring healthcare video

1. HeyGen: Best overall for a recurring healthcare video program

• Score: 9.2/10

• Entry price: $24/mo billed annually, $29/mo billed monthly
• Cost for 12 patient-education videos: $288/year, $6.00 per finished minute
• Metering: Credits, at Avatar IV/V 20 per minute, Avatar III 3 per minute, lip-synced translation 5 per minute
• Volume cliff: 600 credits/month on Creator, about 30 premium avatar minutes per month
• Free tier: 3 videos/month with a watermark
• Reviewed on: Creator plan, Avatar V, September 2026

The priced job fits inside one Creator plan at $288 a year, using 680 of its 7,200 annual credits.

What it wins: the second year. A protocol change is a script edit and a re-render: my brief's two month-seven updates cost 80 credits.

How it works in practice: HeyGen builds a digital twin from one 15-second recording that captures appearance, voice, motion, and consent, so the clinician presenting your library records once rather than every quarter. The June 2026 long-form release renders 30 minutes of talking-head video in one pass, identity locked throughout.

The Spanish half of my brief runs through the AI video translator at 5 credits per minute with lip sync, a fifth of the English cost. Approved clinical documents go straight into the PDF to video workflow.

Where it falls short: clinical fidelity at the top end. HeyGen scored 8.7 on accuracy against Random42 at 9.7 and XVIVO at 9.4, losing that category outright. It films nothing, and it animates nothing sub-cellular.

Client example: Komatsu reports training completion near 90% after moving its training video to HeyGen (https://www.heygen.com/customer-stories/komatsu). No HeyGen healthcare story publishes a measurable delta.

Pros:

• One 15-second recording produces a reusable presenter, so a clinician never re-records for an update
• Lip-synced translation across 175+ languages at 5 credits per minute
• 30 minutes of single-pass generation covers a full training module, not a clip
• SOC 2 Type II, GDPR, CCPA, SSO, and audit logs, and customer data is never used for model training

Cons:

• Premium avatar models draw from a monthly credit pool, and heavy Avatar V use can outrun the Creator allocation
• The credit math takes a few minutes to learn even after the 2026 relabeling

Category scores: Review handling 9.3 | Cost 9.6 | Accuracy 8.7 | Turnaround 9.6 | Recurring fit 9.2 | Rights 8.6

2. Knowlify: Best document-to-video partner for service-line volume

• Score: 8.3/10

• Entry price: Not published
• Cost for 12 patient-education videos: Not published
• Metering: Not published; self-serve platform tier plus quoted studio work
• Volume cliff: Not published
• Free tier: Free start advertised on its site
• Reviewed on: Published platform and studio pages, September 2026

The priced job cannot be costed from published figures, which cost Knowlify most of the 1.2 points between it and HeyGen.

What it wins: the two-speed model. Knowlify runs a self-serve document-to-video platform and a custom studio in the same company, so the routine explainer and the harder asset do not need two vendors.

How it works in practice: Knowlify's published healthcare comparison is the most honest piece of vendor content I read during this scoring pass, and it argues the point most ranking pages miss: medical animation is a regulated production category with its own review chains rather than a style of explainer video. Its own framework asks buyers to define the work, match the accuracy requirement, then compare iteration speed and compliance fit before comparing portfolios.

The platform tier converts approved documents into narrated video, which suits the service-line backlog most health systems already have sitting in PDF form.

Where it falls short: self-ranking and unpublished numbers. Knowlify places itself first in its own comparison and publishes price and speed claims about competitors that I could not verify independently, so I scored its accuracy category on portfolio evidence alone at 7.6.

Client example: no verifiable public client result with a time or cost delta as of September 2026.

Pros:

• Self-serve platform and custom studio under one contract, so routine and hero assets share a vendor
• Published buyer framework covering accuracy needs, iteration speed, and compliance fit
• Document-to-video input matches how health systems already store approved content
• Publicly separates patient education, general healthcare explainers, and high-end 3D medical animation as different purchases

Cons:

• No published per-video price or turnaround that a buyer can plan a budget against
• Ranks itself first in its own comparison content, so its competitor claims need independent checking

Category scores: Review handling 8.4 | Cost 8.8 | Accuracy 7.6 | Turnaround 8.8 | Recurring fit 8.2 | Rights 7.4

Tier 2: Full-service live-action healthcare production companies

3. Demo Duck: Best documented medical and legal review workflow

• Score: 8.0/10
• Entry price: $18,000 per animated project, published
• Cost for 12 patient-education videos: $216,000 at the published low end, no package rate published
• Metering: Per project, quoted
• Volume cliff: Not published; each project is scoped separately
• Free tier: None
• Reviewed on: Published healthcare service page and pricing statements, September 2026

One two-minute animated video at Demo Duck's published $18,000 floor works out to $9,000 per finished minute before the Spanish version.

What it wins: review architecture. Demo Duck publishes that medical-team or advisory-board review of visual accuracy and legal review should happen at script and storyboard, before animation is finalized, and that is the single most expensive lesson in healthcare video written down for free.

How it works in practice: the published healthcare catalogue covers educational series, patient education, public-service announcements, compliance content, and sales video, which is a wider brief than most live-action shops advertise. Demo Duck also publishes its own ranges, at roughly $18,000 to $25,000 for animation and $25,000 to $45,000 for live action, typically running 8 to 12 weeks depending on complexity. Those are Demo Duck's figures for Demo Duck's work, and they are not an industry average, but they are the only published price ranges I found from a live-action healthcare producer.

Where it falls short: the recurring program. Demo Duck scored 6.8 on cost and 6.5 on turnaround, because an 8 to 12 week cycle and a five-figure project price do not compress when you order the twelfth video.

Client example: Demo Duck publishes healthcare work and process detail, but no verifiable client result with a time or cost delta attached.

Pros:

• Publishes its own price ranges, which almost no competitor in this list does
• Names the exact review checkpoints, at script and storyboard, where medical and legal input belongs
• Covers animation and live action in one shop, so a series can mix formats
• Published 8 to 12 week timeline gives a planner something real to schedule against

Cons:

• A published $18,000 floor per animated project puts a twelve-video year out of reach for most service-line budgets
• Every content update is new scope, so a protocol change restarts the quote

Category scores: Review handling 9.2 | Cost 6.8 | Accuracy 8.8 | Turnaround 6.5 | Recurring fit 8.4 | Rights 7.8

4. Solvis Media: Best breadth of live-action healthcare formats

• Score: 7.3/10
• Entry price: Not published
• Cost for 12 patient-education videos: Not published
• Metering: Per project, quoted
• Volume cliff: Not published
• Free tier: None
• Reviewed on: Published healthcare video production service pages, September 2026

Solvis Media publishes no rate card, so a buyer cannot size the priced job without a sales conversation.

What it wins: format coverage from one crew. Corporate and brand video, patient education, testimonials, explainers, healthcare commercials, virtual facility tours, training, and patient stories all sit in one published catalogue.

How it works in practice: the strongest idea on the Solvis pages is audience translation, meaning the deliberate simplification of medical jargon so a patient understands it, which is the actual failure mode of most hospital video. Its published positioning also treats patient confidentiality as a production consideration rather than an afterthought, though the authoritative guidance on that belongs to HHS rather than to any agency page.

Where it falls short: evidence. One claim on the Solvis pages, that sites with video see a 157% organic traffic increase, traces to no primary study I could locate, and I excluded it from this article rather than repeat it. Nothing published names the clinical reviewers or the on-set privacy protocol either, which is what held its review score to 7.4.

Client example: no verifiable public client result with a time or cost delta as of September 2026.

Pros:

• Nine distinct healthcare formats published on one service page, including virtual facility tours
• Explicit focus on translating clinical language into patient-readable scripts
• Live-action patient stories and testimonials, which no platform in Tier 1 can produce
• Treats patient confidentiality as a pre-production planning item

Cons:

• Carries an unsourced 157% traffic statistic, which is a caution sign on any vendor's evidence standard
• No published pricing, timeline, or revision policy to plan a program against

Category scores: Review handling 7.4 | Cost 6.8 | Accuracy 8.0 | Turnaround 6.6 | Recurring fit 7.8 | Rights 7.4

5. 44 Studios: Best fully in-house live-action crew

• Score: 7.2/10
• Entry price: Not published
• Cost for 12 patient-education videos: Not published
• Metering: Per project, quoted
• Volume cliff: Not published
• Free tier: None
• Reviewed on: Published medical and biotech video production pages, September 2026

44 Studios quotes per project and publishes no starting figure, so the twelve-video year is a proposal rather than a price.

What it wins: single-team accountability. 44 Studios states that it handles creative direction, filming, post-production, and multi-platform delivery in-house, which removes the subcontractor handoff where healthcare scripts usually lose accuracy.

How it works in practice: the published client mix runs across hospitals, medical groups, dental practices, biotech, and medical device launches, and the site describes its healthcare work as HIPAA-conscious rather than claiming blanket compliance, which is the more defensible framing. Its published process is conventional and clearly written: storyboard, production schedule, shoot, B-roll, color, graphics, revision round.

Its published FAQ answers the question most agency sites avoid, naming the specific healthcare formats it produces: dental marketing videos, pharma explainer videos, hospital recruitment videos, scientific video for research institutions, and device-launch content.

Where it falls short: healthcare-specific review. 44 Studios scored 7.0 on review handling because its published process describes a generic revision round rather than named clinical or legal checkpoints, and nothing published names a clinical reviewer or a PHI protocol for on-site days.

Client example: the site references hospitals, medical groups, and healthcare startups, but publishes no client result with a measurable delta.

Pros:

• Creative, production, and post handled by one in-house team in Los Angeles
• Published workflow covers storyboard, schedule, B-roll, color, and graphics as discrete steps
• Client mix spans hospitals, dental, biotech, and device launches
• Describes its work as HIPAA-conscious rather than making a blanket compliance claim

Cons:

• No named clinical or legal review checkpoint in the published process
• Regional crew model means on-location work outside its area adds travel scope

Category scores: Review handling 7.0 | Cost 6.9 | Accuracy 8.2 | Turnaround 6.6 | Recurring fit 7.4 | Rights 7.0

6. Elephant Productions: Best regional shop for patient and staff education

• Score: 7.0/10
• Entry price: Not published
• Cost for 12 patient-education videos: Not published
• Metering: Per project, quoted
• Volume cliff: Not published
• Free tier: None
• Reviewed on: Published company profile and service descriptions, September 2026

Elephant Productions publishes no rates, and at nineteen staff it is the smallest live-action operation I scored.

What it wins: proximity. An Austin-based team of nineteen means the producer who takes the brief is the producer on set, which matters when a charge nurse changes the filming plan an hour before the shoot.

How it works in practice: the published focus covers corporate, technology, medical and healthcare, and education clients, with patient education and employee training named explicitly alongside classroom and social-awareness work. That mix suits a regional provider producing a handful of assets a year rather than a national content program.

The published remit also covers interactive and multimedia work for marketing, classroom education, employee training, and social-awareness campaigns, which fits a provider whose video needs sit next to its education needs.

Where it falls short: scale and specialization. Elephant Productions scored 6.8 on review handling and 7.6 on accuracy because nothing published names clinical reviewers, scientific staff, or a regulated-content process, and no surgical or device work appears in the public portfolio.

Client example: no verifiable public client result with a time or cost delta as of September 2026.

Pros:

• Nineteen-person team, so the producer on the call is the producer on set
• Published focus includes both patient education and employee training
• Covers interactive and multimedia deliverables alongside video
• Long-running Austin operation with a named owner and executive producer

Cons:

• No published clinical review process, scientific staff, or regulated-content workflow
• Small team limits parallel production, so a twelve-video year queues rather than runs concurrently

Category scores: Review handling 6.8 | Cost 6.6 | Accuracy 7.6 | Turnaround 6.8 | Recurring fit 7.4 | Rights 7.0

7. Busy Boy Productions: Best budget entry point for basic clinical filming

• Score: 6.7/10
• Entry price: Not published
• Cost for 12 patient-education videos: Not published
• Metering: Per project, quoted
• Volume cliff: Not published
• Free tier: None
• Reviewed on: Published medical video service and comparison pages, September 2026

Busy Boy Productions publishes no rate card, and its own comparison content is where most buyers first encounter it.

What it wins: service-category clarity for a first purchase. Its published breakdown separates surgical procedure filming, patient interviews, training, medical device demos, educational video, animation, and event coverage, which is a genuinely useful map for a practice that has never bought video.

How it works in practice: the full-service description covers lighting, sound, editing, color correction, motion graphics, and captions, and the company ranks for the exact term buyers search while placing itself first in its own list. That self-ranking is the reason I used its service categories and ignored its ordering.

Where it falls short: everything downstream of the first video. Busy Boy Productions scored 6.4 on review handling, the lowest in this article, because no published material addresses clinical accuracy review, legal review, or PHI handling on set.

Client example: no verifiable public client result with a time or cost delta as of September 2026.

Pros:

• Publishes the clearest service-category map for a first-time medical video buyer
• Covers surgical filming, testimonials, device demos, and event coverage in one shop
• Full post-production chain named, including color correction and captions
• Ranks for the exact buyer search term, so its briefing language matches how buyers describe the work

Cons:

• No published guidance on clinical review, legal review, or PHI handling during a shoot
• Places itself first in its own comparison list, so the ranking carries a commercial conflict

Category scores: Review handling 6.4 | Cost 6.4 | Accuracy 7.4 | Turnaround 6.6 | Recurring fit 6.8 | Rights 6.8

Tier 3: Specialist scientific and 3D medical animation studios

8. Nucleus Medical Media: Best licensed patient-education library

• Score: 7.9/10
• Entry price: Not published
• Cost for 12 patient-education videos: Not published; licensing is quoted separately from custom work
• Metering: Licensing and custom project quotes
• Volume cliff: Not published
• Free tier: None
• Reviewed on: Published library, custom animation pages, and industry profiles, September 2026

Nucleus Medical Media is the only company in this list where the cheapest route is buying an animation that already exists.

What it wins: breadth of pre-made clinically reviewed content. Its animation library covers conditions and procedures across specialties and is used by hospitals, universities, and media outlets, which means a health system can cover thirty conditions without commissioning thirty films.

How it works in practice: the studio runs one of the largest teams of medical illustrators and animators in the field, with CAAHEP-accredited animators trained at programs including Johns Hopkins, the Medical College of Georgia, and the University of Toronto. It produces custom pharmaceutical, medical device, and education work alongside the library, and its scoring strength comes from having clinically trained people making the visual decisions rather than a generalist motion designer interpreting a brief.

Where it falls short: the library is not your library. Licensed animation carries no institutional branding, no named clinician, and no local protocol detail, which is exactly what makes patient-education video feel like it came from your hospital.

Client example: published partnerships include Nature, Boston Scientific, and the World Health Organization, with no time or cost delta published.

Pros:

• Pre-built clinically reviewed animation library covering many conditions and procedures
• CAAHEP-accredited medical animators from named graduate programs on staff
• Custom work available for device, pharmaceutical, and education briefs
• Licensing removes the review cycle entirely for standard anatomical and procedural explanations

Cons:

• Licensed content cannot carry your branding, clinicians, or local protocol specifics
• No published pricing for licensing or custom production

Category scores: Review handling 8.6 | Cost 6.4 | Accuracy 9.2 | Turnaround 6.8 | Recurring fit 8.0 | Rights 8.2

9. Random42: Best pharma mechanism-of-action animation

• Score: 7.5/10
• Entry price: Not published
• Cost for 12 patient-education videos: Not published; a published third-party comparison puts premium MoA animation near $50,000 per 60 seconds
• Metering: Per project, quoted
• Volume cliff: Not published
• Free tier: None
• Reviewed on: Published studio pages, portfolio, and company profiles, September 2026

Random42 is the wrong purchase for my priced job and the right purchase for the asset my priced job could never produce.

What it wins: the highest clinical and scientific fidelity in this article, at 9.7 out of 10. Nothing else I scored comes close on molecular mechanism work.

How it works in practice: founded in 1992 in London and focused on pharmaceutical and biotech visualization, Random42 has worked with all of the top 25 global pharmaceutical companies and has expanded into VR, AR, and interactive scientific communication. PhD-qualified scientists work on projects alongside the animators, which is the structural reason its accuracy score sits where it does: the science review is inside the studio rather than bolted on at the end.

Where it falls short: cost and cadence for routine work. Random42 scored 4.6 on cost and 4.6 on turnaround against my brief, because a hero MoA asset is a twelve-week, five-figure engagement and a patient-education library is neither.

Client example: the studio publishes relationships with the top 25 global pharmaceutical companies and more than 200 awards, with no client result carrying a time or cost delta.

Pros:

• Highest accuracy score in this article at 9.7, on molecular and mechanism-of-action work
• PhD-qualified scientists work on projects, so scientific review happens inside production
• Thirty-four years of continuous specialization in pharmaceutical visualization
• VR, AR, and interactive formats available for congress and medical-affairs use

Cons:

• Premium project pricing and multi-week cycles rule it out for routine content volume
• A London base adds time-zone friction for US teams running same-week review cycles

Category scores: Review handling 9.4 | Cost 4.6 | Accuracy 9.7 | Turnaround 4.6 | Recurring fit 8.6 | Rights 7.6

10. Ghost Productions: Best surgical technique and medical device animation

• Score: 7.1/10
• Entry price: Not published
• Cost for 12 patient-education videos: Not published
• Metering: Per project, quoted
• Volume cliff: Not published
• Free tier: None
• Reviewed on: Published studio description, portfolio, and client list, September 2026

Ghost Productions prices per project and publishes no figures, which is standard for this tier and still a scoring penalty.

What it wins: surgical specificity. The studio describes itself as a medical animation and VR surgical simulation company, and the work is aimed at surgeons and device sales rather than at patients.

How it works in practice: based in Roseville, Minnesota, in the middle of the US orthopedic device cluster, Ghost Productions has produced promotional marketing, surgical technique, and surgeon and patient education for more than fifteen years. The published client list includes Medtronic, Johnson & Johnson, Zimmer, Stryker, and National Geographic, and the VR surgical simulation work is a capability almost nobody else in this list offers.

The published portfolio also spans broadcast-adjacent work for National Geographic and A&E, which is unusual for a studio whose core business is device marketing and surgeon education.

Where it falls short: patient-facing volume. Ghost Productions scored 5.2 on cost and 4.6 on turnaround for my brief, and its strengths sit in a format where the audience is a surgeon evaluating a technique rather than a patient preparing for one.

Client example: published clients include Medtronic, Johnson & Johnson, Zimmer, and Stryker, with no published result carrying a measurable delta.

Pros:

• VR surgical simulation alongside animation, which few competitors in this list offer
• Fifteen-plus years of surgical technique work for named orthopedic device manufacturers
• Located inside the US medical device cluster, so in-person engineering reviews are practical
• Covers both surgeon-facing and patient-facing education from the same studio

Cons:

• Project-quoted premium work does not scale to a recurring patient-education calendar
• No published pricing, timeline, or revision terms of any kind

Category scores: Review handling 8.4 | Cost 5.2 | Accuracy 9.0 | Turnaround 4.6 | Recurring fit 7.2 | Rights 7.2

11. XVIVO: Best molecular and cellular cinematography

• Score: 6.9/10
• Entry price: Not published
• Cost for 12 patient-education videos: Not published
• Metering: Per project, quoted
• Volume cliff: Not published
• Free tier: None
• Reviewed on: Published studio pages, portfolio, and industry profiles, September 2026

XVIVO sits last on my composite and first on a criterion my brief barely weighted, which is the clearest illustration of why published weights matter.

What it wins: cinematic molecular visualization. XVIVO produced "The Inner Life of the Cell" for Harvard University, and its documentary-style approach to cellular biology is the reference point other studios get compared against.

How it works in practice: the American studio works across therapeutic areas with PhD scientists and medical writers on staff, serving researchers, universities, and biotech companies that need high-fidelity visualization of microscopic processes. The intersection it aims for is aesthetic and scientific at once, and its portfolio is the strongest argument in this article that scientific animation is a separate profession rather than an explainer-video upgrade.

Where it falls short: every requirement my brief named. XVIVO scored 4.0 on cost and 4.2 on turnaround, and a pre-operative patient explainer is not the work this studio exists to do.

Client example: Harvard University's "The Inner Life of the Cell" is the published reference work, with no commercial result carrying a time or cost delta.

Pros:

• Produced "The Inner Life of the Cell" for Harvard University, the field's most-cited reference animation
• PhD scientists and medical writers on staff across therapeutic areas
• Documentary-style cinematography that holds up in scientific and investor settings
• Coverage across research, biotech, and pharmaceutical audiences from one studio

Cons:

• Wrong economics for routine patient education, scoring 4.0 on cost against my brief
• No published pricing or timeline, so budgeting requires a scoping call before any number exists

Category scores: Review handling 8.8 | Cost 4.0 | Accuracy 9.4 | Turnaround 4.2 | Recurring fit 7.0 | Rights 7.0

What twelve patient-education videos cost in year one

The job: twelve two-minute patient-education videos in the first year, 1080p with captions, in English and Spanish, two rounds of clinical review each, with two of the twelve re-cut after a protocol change at month seven. That is 48 finished minutes of video and 24 deliverables.

All figures verified September 2026. Every "Not published" below is a published-terms finding, not a gap in my research.

Checking the HeyGen row. Twelve videos at two minutes each is 24 minutes of English video. At Avatar V's rate of 20 credits per minute that is 480 credits. The Spanish versions run through lip-synced translation at 5 credits per minute, so 24 minutes costs 120 credits. The two month-seven updates are 4 minutes re-rendered at 20 credits per minute, or 80 credits. Total: 680 credits for the year, against the Creator plan's 600 credits per month. The plan costs $24 per month billed annually, so $288 for the year, across 48 finished minutes, which is $6.00 per finished minute.

The crossover. Würth Group reports an 80% cut in translation costs after moving localization to HeyGen (https://www.heygen.com/customer-stories/wurth-group), which is the same mechanic the Spanish half of this brief runs on. For routine patient education, the crossover is below one video: HeyGen's entire $288 year costs 1.6% of one published $18,000 Demo Duck animation. The real crossover is not volume, it is video type.

The first deliverable that needs a camera in a clinical space, a surgeon on set, or a molecular-level 3D sequence crosses to an agency immediately, at video one, and no subscription changes that.

The exit cost. HeyGen's published terms state that unused credits do not carry over after cancellation, and previous-cycle credits expire when a subscription lapses, while finished renders download normally and customer data is not used for model training.

For the nine agencies and studios, ownership of raw footage, project files, and animation source assets is negotiated per contract and none of them publishes standard terms, which is the single largest documentation gap in this category. Put file ownership and post-termination usage rights in the statement of work before signing, because nothing on any of these websites will answer it for you.

Which one is overpriced for this job. Demo Duck's published $18,000 floor for one animated project is 62x HeyGen's $288 year for the entire twelve-video brief, and Demo Duck scored 8.0 against HeyGen's 9.2.

What the difference buys is real: Demo Duck publishes the clearest medical and legal review process of any company here, it publishes its prices at all, and it can put a camera somewhere a platform cannot. For one hero asset that is worth the money, and for twelve routine explainers the arithmetic does not survive contact with a budget.

Medical video production companies compared: capabilities and terms

Verified September 2026. Every row names the company, so no cell depends on the row above it.

The matchups buyers compare most often

Which medical video partner is for you

By the work in front of you

Twelve or more routine patient-education or staff-training videos a year, in more than one language: HeyGen.

A backlog of approved clinical PDFs that needs to become video without a shoot: Knowlify.

One polished hero asset with physicians on camera and a defensible review trail: Demo Duck.

A pharmaceutical launch needing a mechanism-of-action film: Random42.

A surgical technique or orthopedic device explanation for a clinician audience: Ghost Productions.

Thirty common conditions covered quickly without commissioning anything: Nucleus Medical Media.

By budget

Under $500 a year: HeyGen at $288 on annual billing is the only option in this article that fits, and the free tier's three watermarked videos a month will tell you whether the output clears your internal bar before you pay anything.

Between $500 and $20,000 a year: HeyGen for the recurring library plus one commissioned asset. At Demo Duck's published $18,000 floor, that budget buys one animated video and nothing else, so the sequencing matters more than the vendor.

Over $50,000 a year: split the budget. A premium studio such as Random42 or XVIVO for the hero asset, and a platform or document-to-video partner for the derivative content, which is the two-vendor pattern most healthcare teams end up at anyway.

By how fast you need the first video

Same day: HeyGen, where the path from approved script to a rendered 1080p file is minutes rather than weeks.

Four to six weeks: Knowlify's studio tier or a regional live-action shop such as Elephant Productions or 44 Studios, assuming your reviewers move quickly.

Eight to twelve weeks: Demo Duck publishes that range for its own work, and the premium animation studios run at or beyond it. Start the clinical review conversation on day one of that window, not at week six.

Too new to rank

Three routes showed up during this scoring pass that I could not score responsibly yet.

Document-to-video platform tiers sold alongside a traditional studio are new enough that no buyer I could verify has run a full year of healthcare content through one. Knowlify is the clearest example in this list, and I will retest once there is a published twelve-month healthcare deployment with numbers attached.

Code-to-video and URL-to-video pipelines, including HyperFrames, which HeyGen shipped between April and June 2026, turn a webpage or a document into a rendered video through an automated skill rather than an editor.

The healthcare question nobody has answered is how an automated pipeline handles a clinical reviewer's change request, so I left it unscored.

The phrase "HIPAA-compliant crew" is now common on production company websites, and I found no company publishing the business associate agreement terms or on-set safeguards behind it. Treat the phrase as a question to ask rather than a credential, and ask for the BAA in writing.

The review chain that decides your budget: medical, legal, and privacy checkpoints

The most expensive mistake in healthcare video is not choosing the wrong company. It is running the review chain in the wrong order, and it costs the same whether you spend $288 or $45,000.

Checkpoint 1, before a script exists: name your reviewers. Identify the clinician who signs off on accuracy, the legal or compliance reviewer, and, for anything promotional about a prescription product, the regulatory reviewer. Agree who can request changes and who can only comment, because an unnamed reviewer appearing at week ten is what turns a fixed quote into a change order.

Checkpoint 2, at script: clinical accuracy. Demo Duck's published healthcare process puts medical-team or advisory-board review of visual accuracy at the script and storyboard stage rather than after animation, and every dollar figure in this article supports that sequencing. A catheter angle corrected in a script costs a sentence. The same correction after a 3D render costs a re-render.

Checkpoint 3, at storyboard: legal and regulatory. For prescription drug promotion, FDA's Office of Prescription Drug Promotion reviews promotional communications and states that advertisements cannot be false or misleading, cannot omit material facts, and must present a fair balance between effectiveness and risk information. FDA also points to 21 CFR 202.1(e)(7)(viii), under which an advertisement may be misleading if it fails to present side effects and contraindications with prominence and readability reasonably comparable to the effectiveness information. Prominence is a storyboard decision: type size, contrast, layout, white space, and how long the risk copy stays on screen. Deciding it after the edit is locked is how a compliant script becomes a non-compliant video. The enforcement ladder here is civil and regulatory rather than criminal: OPDP issues untitled letters and warning letters and can require corrective advertising.

Checkpoint 4, before anyone books a shoot day: patient privacy. This is the checkpoint most production companies gloss and the one with published federal guidance behind it. HHS states that health care providers cannot invite or allow media personnel, including film crews, into treatment areas or other areas where patients' PHI will be accessible in written, electronic, oral, or other visual or audio form. Without prior written authorization from each individual who is in the area or whose PHI will be accessible.

HHS also states that requiring the crew to mask identities afterward, by blurring, pixelation, or voice alteration, is not sufficient, because prior express authorization is always required. Even with authorizations in hand, providers must keep reasonable safeguards in place, and HHS names examples such as privacy screens on monitors and opaque barriers so patients who have not authorized filming are not recorded. OCR has brought civil enforcement against hospitals over film crew access, so this is a settlement-and-penalty exposure for the provider rather than a production detail to delegate to the crew.

Checkpoint 5, at delivery: plan the update. Ask how version two happens before you approve version one. On a platform workflow an update is an edited script and a new render. On a shoot it is a crew, a room, a clinician's calendar, and a fresh authorization set, which is the real reason healthcare video libraries go stale rather than wrong.

Two of those five checkpoints have nothing to do with which company you hire, and they are the two that most often break a schedule.

The bottom line

HeyGen takes the top spot at 9.2 out of 10 for one reason: a protocol change becomes a re-render instead of a reshoot, which is what makes a twelve-video year cost $288 rather than a five-figure invoice per asset. Demo Duck is the one to call for a hero asset with a defensible review trail. Random42 owns pharmaceutical mechanism-of-action work. Nucleus Medical Media is the fastest route to broad condition coverage. HeyGen's free plan gives three videos a month, so run one of your approved patient-education scripts through it and judge the output yourself.

Frequently asked questions

How do I choose a medical video production company?

Start with the deliverable, not the vendor list. A physician interview, a device demo, a patient explainer, and a mechanism-of-action animation are four different specialties, and the company that is excellent at one is usually mediocre at another. Then compare review workflow and update cost.

How much does medical video production cost?

The only published US figures I found come from Demo Duck, at roughly $18,000 to $25,000 for animation and $25,000 to $45,000 for live action, typically over 8 to 12 weeks. Platform production is a different order: HeyGen's Creator plan is $288 a year.

How long does healthcare video production take?

Eight to twelve weeks for a commissioned project, per Demo Duck's published range, and that clock assumes your reviewers respond promptly. Script-driven platform production takes minutes per render, so the schedule becomes your internal review cycle rather than the production.

Can a film crew record inside a hospital or clinic?

Only with prior written authorization from every patient whose PHI will be accessible, per HHS guidance. Blurring faces afterward does not substitute for that authorization. Even with authorizations, providers must keep safeguards like privacy screens and barriers in place during filming.

Are medical video production companies HIPAA compliant?

That phrase belongs to the provider, not the vendor. HIPAA obligations sit with the covered entity, so ask for a signed business associate agreement, named on-set safeguards, and written authorization procedures rather than accepting "HIPAA-compliant" as a capability claim on a website.

What is the difference between medical animation and healthcare video production?

Medical animation is a regulated visualization specialty with scientists in the production team, used for mechanism of action, surgical technique, and anatomy. Healthcare video production is live-action work: physicians, facilities, patients, testimonials. Different crews, different price ranges, different review chains.

Is HeyGen or Demo Duck better for patient education videos?

HeyGen, at 9.2 versus 8.0, for a recurring library: $288 a year against a published $18,000 per project, with Spanish versions at 5 credits per minute. Demo Duck wins the moment the video needs a real clinician filmed on location.

Is the free option any good for medical video?

HeyGen's free tier gives three videos a month with a watermark, which is enough to check whether the output clears your clinical reviewer's bar. It is not publishable for patient-facing use. No production company in this article offers a free deliverable.

What is the most common mistake healthcare teams make with video?

Running clinical and legal review after production instead of at script and storyboard. A wording change costs one line in a script and a full re-render after the build. The second most common is buying a shoot for content that changes every six months.

Written byNick Warner